Vergleich

Interleukin-12p40 (IL12p40)

ArtNr 18-731-285098
Hersteller GENWAY
Menge 0,5 mg
Typ Antibody
Applikationen WB
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-BB4BF8
Similar products 18-731-285098
Lieferbar
Genway ID:
GWB-BB4BF8
Immunogen:
Recombinant Human IL12p40 Immunological Activity: Western BlotPH: 7. 2
Buffer:
20mM Phosphate. 150mM Sodium Chloride
Preservative:
0. 09% Sodium Azide
Function:
Cytokine that can act as a growth factor for activated T and NK cells enhance the lytic activity of NK/lymphokine-activated killer cells and stimulate the production of IFN-gamma by resting PBMC.
Function:
Associates with IL23A to form the IL-23 interleukin an heterodimeric cytokine which functions in innate and adaptive immunity. IL-23 may constitute with IL-17 an acute response to infection in peripheral tissues. IL-23 binds to an heterodimeric receptor complex composed of IL12RB1 and IL23R activates the Jak-Stat signaling cascade stimulates memory rather than naive T-cells and promotes production of proinflammatory cytokines. IL-23 induces autoimmune inflammation and thus may be responsible for autoimmune inflammatory diseases and may be important for tumorigenesis.
Subunit:
Heterodimer with IL12A; disulfide-linked. The heterodimer is known as interleukin IL-12. Heterodimer with IL23A; disulfide-linked. The heterodimer is known as interleukin IL-23. Also secreted as a monomer.
Subcellular Location:
Secreted.
Ptm:
Known to be C-mannosylated in the recombinant protein; it is not yet known for sure if the wild-type protein is also modified.
Disease:
Defects in IL12B are a cause of mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950]; also known as familial disseminated atypical mycobacterial infection. This rare condition confers predisposition to illness caused by moderately virulent mycobacterial species such as Bacillus Calmette-Guerin (BCG) vaccine and environmental non-tuberculous mycobacteria and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections with the exception of Salmonella which infects less than 50% of these individuals. The pathogenic mechanism underlying MSMD is the impairment of interferon-gamma mediated immunity whose severity determines the clinical outcome. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood whereas others develop later in life disseminated but curable infections with tuberculoid granulomas. MSMD is a genetically heterogeneous disease with autosomal recessive autosomal dominant or X-linked inheritance.
Similarity:
Belongs to the type I cytokine receptor family. Type 3 subfamily.
Similarity:
Contains 1 fibronectin type-III domain.
Similarity:
Contains 1 Ig-like C2-type (immunoglobulin-like) domain.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0,5 mg
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 11.09.2025 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen